Investors

CureDuchenne Ventures

Exonics’ seed funding was provided by CureDuchenne Ventures (CDV), an organization committed to facilitating the development of drugs to treat Duchenne. CureDuchenne Ventures was formed by CureDuchenne, a national nonprofit that has funded nine research projects that have advanced to human clinical trials. CDV has close ties with the Duchenne community, which includes patients, families, physicians and scientists in academia and industry. These relationships and CDV’s deep knowledge of Duchenne and all therapeutic approaches for the disease were especially important.